Transforming growth factor beta (TGF-β) variants 1, 2, and colony-stimulating factor 1 (CSF1) promotes proliferation and viability in microglia, and inhibitors have been designed with the intent of mediating inflammation associated with neuropathic and cancer pain (Bureta et al., 2019). The gene discussed is CSF1; the disease is cancer.